The Bundibugyo Ebola vaccine is moving into human trials and could make it easier to fight Ebola outbreaks thanks to simpler storage requirements.
SINGAPORE: Hillmann Laboratories has announced that it is speeding up the development of its Bundibugyo Ebola vaccine, a new vaccine that could help control Ebola outbreaks in the Democratic Republic of Congo (DRC).
The Singapore-based company said it plans to move the vaccine into human clinical trials after it was recognised by the World Health Organisation (WHO) as the leading candidate for this strain of the virus.
Related news: Why the Congo Ebola outbreak is becoming harder for health officials to contain
One of the biggest advantages of the new vaccine is that it is much easier to store and transport than existing Ebola vaccines.
The current Ebola vaccine, Ervebo, needs to be kept at extremely low temperatures, making it difficult and expensive to deliver to remote areas. In comparison, the Bundibugyo Ebola vaccine can stay stable for several months in a normal refrigerator.
This means health workers could transport and store the vaccine more easily, especially in rural communities where specialised cold storage is often unavailable.
Also read: France’s first Ebola patient recovers after treatment following Congo humanitarian mission
Better storage also reduces costs and allows vaccines to reach people faster during outbreaks, when quick action is critical to stopping the spread of the virus.
Hillmann Laboratories believes the vaccine could become an important tool in responding to future Ebola outbreaks if clinical trials confirm that it is safe and effective.
The Bundibugyo Ebola vaccine is expected to play an important role in strengthening global efforts to improve outbreak preparedness and protect vulnerable communities.
Babar Siddiqui is the Features Editor at TheBrewNews.com, where he covers stories spanning the environment, culture, and technology. A naturally curious storyteller with an adventurous spirit, he is passionate about exploring ideas that shape the world around us. Beyond the newsroom, Babar finds inspiration in nature, embracing its quiet moments as a source of reflection and creativity.
Connect with him to follow his latest work and insights.
